Literature DB >> 7640037

Relationship between cathepsin D and other pathological and biological parameters in 1752 patients with primary breast cancer.

M Gion1, R Mione, R Dittadi, M Romanelli, L Pappagallo, G Capitanio, U Friede, R Barbazza, A Visonà, S Dante.   

Abstract

The relationship between cathepsin D and other pathological or biological prognostic parameters has not yet been defined through systematic studies in breast cancer. The aim of the present investigation was to define the relationship between cathepsin D and nodal status, tumour size, steroid receptors and tumour grade in a wide patient series. Cytosol cathepsin D was assayed with an immunoradiometric assay in tumour samples from 1752 patients. A statistically significant, but not biologically meaningful association was found between cathepsin D and both tumour size and grade. Cathepsin D was significantly higher in node-positive than in node-negative tumours. However, cathepsin D is not of great use in order to predict the risk of axillary metastases in individual patients, due to overlapping of cathepsin D values between node-positive and node-negative cases. A significant, direct association was found between cathepsin D and both oestrogen receptor and progesterone receptor cytosol levels. Nevertheless, preliminary data indicate that cathepsin D and steroid receptors provide independent prognostic information.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7640037     DOI: 10.1016/0959-8049(94)00532-a

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  6 in total

1.  Cathepsin D detected by automated and quantitative immunohistochemistry in breast carcinomas: correlation with overall and disease free survival.

Authors:  C Charpin; S Garcia; C Bouvier; F Martini; M Lavaut; C Allasia; P Bonnier; L Andrac
Journal:  J Clin Pathol       Date:  1997-07       Impact factor: 3.411

2.  Relationship between cathepsin-D content and disease-free survival in node-negative breast cancer patients: a meta-analysis.

Authors:  G Ferrandina; G Scambia; F Bardelli; P Benedetti Panici; S Mancuso; A Messori
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

3.  Immunoradiometric and immunohistochemical analysis of Cathepsin D in ovarian cancer: lack of association with clinical outcome.

Authors:  G Ferrandina; G Scambia; A Fagotti; G D'Agostino; P Benedetti Panici; A Carbone; S Mancuso
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

4.  Low levels of cathepsin D are associated with a poor prognosis in endometrial cancer.

Authors:  O Falcón; R Chirino; L León; A López-Bonilla; S Torres; L Fernández; J A García-Hernández; P F Valerón; J C Díaz-Chico
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

5.  Time at surgery during menstrual cycle and menopause affects pS2 but not cathepsin D levels in breast cancer.

Authors:  P Pujol; J P Daurès; J P Brouillet; T Maudelonde; H Rochefort; J Grenier
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

6.  Trefoil factor 1 in early breast carcinoma: a potential indicator of clinical outcome during the first 3 years of follow-up.

Authors:  Milan Markićević; Radan Džodić; Marko Buta; Ksenija Kanjer; Vesna Mandušić; Zora Nešković-Konstantinović; Dragica Nikolić-Vukosavljević
Journal:  Int J Med Sci       Date:  2014-05-01       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.